These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 29627891)

  • 1. Anabolic agents: what is beyond osteoporosis?
    Liu Y; Levack AE; Marty E; Or O; Samuels BP; Redko M; Lane JM
    Osteoporos Int; 2018 May; 29(5):1009-1022. PubMed ID: 29627891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
    Bhattacharyya S; Pal S; Chattopadhyay N
    Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis.
    Chew CK; Clarke BL
    Maturitas; 2017 Mar; 97():53-60. PubMed ID: 28159062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abaloparatide and the Spine: A Narrative Review.
    Thompson JC; Wanderman N; Anderson PA; Freedman BA
    Clin Interv Aging; 2020; 15():1023-1033. PubMed ID: 32636617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Importance of teriparatide in the treatment of osteoporosis].
    Yamauchi M
    Clin Calcium; 2016 Jun; 26(6):905-13. PubMed ID: 27230847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
    Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
    Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
    Cosman F; Nieves JW; Dempster DW
    J Bone Miner Res; 2017 Feb; 32(2):198-202. PubMed ID: 27925287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone as an anabolic skeletal therapy.
    Rubin MR; Bilezikian JP
    Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of parathyroid hormone in the treatment of osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):113-21. PubMed ID: 17043762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis.
    Nieves JW; Mosner M; Silverstein S
    N Y State Dent J; 2012; 78(4):30-5. PubMed ID: 23252191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of teriparatide in osteoporotic fracture patients.
    Collinge C; Favela J
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of PTH in the treatment of osteoporosis.
    Borba VZ; Mañas NC
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):213-9. PubMed ID: 20485911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH (1-34): a novel anabolic drug for the treatment of osteoporosis.
    Holick MF
    South Med J; 2005 Nov; 98(11):1114-7. PubMed ID: 16353381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
    Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B
    Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.
    Augustine M; Horwitz MJ
    Curr Osteoporos Rep; 2013 Dec; 11(4):400-6. PubMed ID: 24078470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic skeletal therapy for osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoanabolic and dual action drugs.
    Tabacco G; Bilezikian JP
    Br J Clin Pharmacol; 2019 Jun; 85(6):1084-1094. PubMed ID: 30218587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of parathyroid hormone and teriparatide on fracture healing.
    Campbell EJ; Campbell GM; Hanley DA
    Expert Opin Biol Ther; 2015 Jan; 15(1):119-29. PubMed ID: 25363308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
    Bilezikian JP; Rubin MR
    Curr Osteoporos Rep; 2006 Mar; 4(1):5-13. PubMed ID: 16527002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.